These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8773469)

  • 1. Repeated naltrexone administration accelerates resolution of morphine somatic withdrawal signs in morphine-dependent rats.
    Muntoni AL; Diana M; Gessa GL
    Eur J Pharmacol; 1996 Apr; 301(1-3):R9-10. PubMed ID: 8773469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain.
    Van Bockstaele EJ; Qian Y; Sterling RC; Page ME
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1048-56. PubMed ID: 18367303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats.
    Krystal JH; Compere S; Nestler EJ; Rasmussen K
    Physiol Behav; 1996; 59(4-5):863-6. PubMed ID: 8778878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of naltrexone in the morphine-dependent rat.
    Gellert VF; Holtzman SG
    J Pharmacol Exp Ther; 1979 Dec; 211(3):596-605. PubMed ID: 574545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
    Spanagel R; Almeida OF; Bartl C; Shippenberg TS
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):121-7. PubMed ID: 7862883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence.
    Kalinichev M; Holtzman SG
    J Pharmacol Exp Ther; 2003 Feb; 304(2):603-9. PubMed ID: 12538812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S; Espejo EF; Koob GF; Stinus L
    Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of opioid antagonist efficacy and constitutive opioid receptor activity in the opioid withdrawal syndrome in mice.
    Navani DM; Sirohi S; Madia PA; Yoburn BC
    Pharmacol Biochem Behav; 2011 Oct; 99(4):671-5. PubMed ID: 21736895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barium potentiates the conditioned aversion to, but not the somatic signs of, morphine withdrawal in mice.
    Sato M; Wada K; Funada M
    Eur J Pharmacol; 2005 Sep; 519(3):215-22. PubMed ID: 16122731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
    Olmstead MC; Burns LH
    Psychopharmacology (Berl); 2005 Sep; 181(3):576-81. PubMed ID: 16010543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
    Shoemaker WJ; Kosten TA; Muly SM
    Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppression of deprivation and antagonist-induced withdrawal in morphine-dependent rhesus monkeys.
    Gmerek DE
    Neuropeptides; 1984 Dec; 5(1-3):19-22. PubMed ID: 6099494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys.
    Becker GL; Gerak LR; Koek W; France CP
    Psychopharmacology (Berl); 2008 Dec; 201(3):373-82. PubMed ID: 18726088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
    Bristow LJ; Hogg JE; Hutson PH
    Neuropharmacology; 1997 Feb; 36(2):241-50. PubMed ID: 9144662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.
    White DA; Hwang ML; Holtzman SG
    Pharmacol Biochem Behav; 2005 Jul; 81(3):451-8. PubMed ID: 15907990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine attenuated morphine withdrawal syndrome in the rat.
    Charkhpour M; Jafari RM; Ghavimi H; Ghanbarzadeh S; Parvizpur A
    Drug Res (Stuttg); 2014 Aug; 64(8):393-8. PubMed ID: 24265113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.